featured
2020 Top Stories in Cardiology: SOLOIST and SCORED
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Bhatt DL, Szarek M, Steg PG, et al. Sotagliflozin in Patients With Diabetes and Recent Worsening Heart Failure. N Engl J Med. 2020 Nov 16. DOI: 10.1056/NEJMoa2030183. Online ahead of print.
- Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure - SOLOIST-WHF. Presented by Dr. Deepak Bhatt at the American Heart Association Virtual Scientific Sessions, November 16, 2020.
- Bhatt DL, Szarek M, Pitt B, et al. Sotagliflozin in Patients With Diabetes and Chronic Kidney Disease. N Engl J Med. 2020 Nov 16. DOI: 10.1056/NEJMoa2030186. Online ahead of print.
- Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk – SCORED. Presented by Dr. Deepak Bhatt at the American Heart Association Virtual Scientific Sessions, November 16, 2020.
Disclosure statements are available on the authors' profiles: